Trial Profile
A phase 1 study of TS-1 and sorafenib combination therapy in patients with advanced hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- 09 Oct 2009 New trial record